NCT03907813 is a Phase 4 clinical trial of Exparel in Pain, Postoperative, sponsored by Wright State University.

Who is sponsoring NCT03907813?

NCT03907813 is sponsored by Wright State University.

What drugs are being tested in NCT03907813?

Interventions in NCT03907813: Exparel, Saline infiltration.

What condition does NCT03907813 study?

NCT03907813 studies Pain, Postoperative, Opioid Use.

Is NCT03907813 still recruiting?

NCT03907813 is currently withdrawn. Last updated 31 July 2020.

Last reviewed 2020-07-31 · How we verify

NCT03907813

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Liposomal Bupivacaine After Cesarean Delivery

Withdrawn Phase 4 Last updated 31 July 2020

What this trial tests

Phase 4 trial testing Exparel in Pain, Postoperative. Withdrawn.

Timeline

1 May 2019

Primary endpoint
30 June 2020

31 July 2020

Quick facts

Lead sponsor	Wright State University
Phase	Phase 4
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Start date	1 May 2019
Primary completion	30 June 2020
Estimated completion	31 July 2020
Sites	1 location across United States

Drugs / interventions tested

Exparel — full drug profile →
Saline infiltration — full drug profile →

Conditions studied

Pain, Postoperative — all drugs for Pain, Postoperative →
Opioid Use — all drugs for Opioid Use →

Sponsor

Wright State University

Who can join

Adults 18 to 45, female only, with Pain, Postoperative or Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine if local wound infiltration with liposomal bupivacaine at the time of cesarean delivery can decrease opioid use and provide adequate post-operative pain control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exparel

Trials testing the same drug.

NCT06349772 — Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy · EARLY_PHASE1 · recruiting
NCT06574022 — Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks · Phase 4 · recruiting
NCT06619340 — EXPAREL IPSA Block in Knee Arthroplasty · Phase 4 · enrolling by invitation
NCT06350981 — Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion · Phase 2, PHASE3 · enrolling by invitation
NCT06274008 — Exparel vs. ACB With Bupivacaine for ACL Reconstruction · Phase 1 · unknown

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting

Other Wright State University trials

Trials by the same sponsor.

NCT06597123 — AI-Augmented Motivational Interviewing Training for Primary Care · NA · not yet recruiting
NCT06310200 — Sphenopalatine Ganglion Block and Cold Induced Headaches · Phase 1 · active not recruiting
NCT06312813 — Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With · Phase 2 · recruiting
NCT05696964 — Improving Relationships Using Motivational Interviewing · NA · withdrawn
NCT06663241 — The Validation of New Photographic Technology for Assessing Skin Lesions · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03907813 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wright State University
Last refreshed: 31 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing